Fuan Pharmaceutical (Group) Balance Sheet Health
Financial Health criteria checks 5/6
Fuan Pharmaceutical (Group) has a total shareholder equity of CN¥4.4B and total debt of CN¥709.9M, which brings its debt-to-equity ratio to 16.1%. Its total assets and total liabilities are CN¥6.0B and CN¥1.6B respectively. Fuan Pharmaceutical (Group)'s EBIT is CN¥258.4M making its interest coverage ratio -3.2. It has cash and short-term investments of CN¥969.1M.
Key information
16.1%
Debt to equity ratio
CN¥709.91m
Debt
| Interest coverage ratio | -3.2x |
| Cash | CN¥969.06m |
| Equity | CN¥4.40b |
| Total liabilities | CN¥1.64b |
| Total assets | CN¥6.04b |
Recent financial health updates
Recent updates
Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Shares Fly 36% But Investors Aren't Buying For Growth
Oct 08
There's No Escaping Fuan Pharmaceutical (Group) Co., Ltd.'s (SZSE:300194) Muted Earnings
Aug 23Does Fuan Pharmaceutical (Group) (SZSE:300194) Have A Healthy Balance Sheet?
Jun 07Fuan Pharmaceutical (Group)'s (SZSE:300194) Shareholders May Want To Dig Deeper Than Statutory Profit
May 02Insufficient Growth At Fuan Pharmaceutical (Group) Co., Ltd. (SZSE:300194) Hampers Share Price
Apr 03Financial Position Analysis
Short Term Liabilities: 300194's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.3B).
Long Term Liabilities: 300194's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥326.9M).
Debt to Equity History and Analysis
Debt Level: 300194 has more cash than its total debt.
Reducing Debt: 300194's debt to equity ratio has increased from 1.3% to 16.1% over the past 5 years.
Debt Coverage: 300194's debt is well covered by operating cash flow (65.1%).
Interest Coverage: 300194 earns more interest than it pays, so coverage of interest payments is not a concern.